Skip to main
  1. Stocks
  2. Ceribell Inc
  3. Forecast
CBLL

Ceribell Inc (CBLL) Stock Forecast & Price Target

Ceribell Inc (CBLL) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CeriBell is attractive fundamentally because it combines a first-mover position in point-of-care rapid EEG with a differentiated AI-enabled platform that addresses an underserved ICU and ED workflow, allowing bedside deployment in minutes and supporting faster, more data-driven treatment decisions. Its outlook is reinforced by sustained near-30% sales growth, a raised FY26 revenue guide of $114M-$117M, 92.3% gross margin, 712 active hospitals, and a still-low sub-4% penetration in the core seizure market, which leaves substantial room for expansion. Additional upside comes from FDA-cleared pediatric/neonate and delirium indications, a late-stage stroke program, and a product pipeline that should deepen utilization, widen its $3.5B+ TAM, and support eventual profitability with cash on hand.

Bears say

CeriBell is facing a weak fundamental setup driven by subpar financial results, slower-than-expected adoption, and the risk that expanded indications such as delirium and stroke fail to deliver meaningful clinical or commercial upside. Heightened competition from conventional EEG systems and new point-of-care offerings, along with unfavorable insurance coverage and reimbursement dynamics, could further pressure utilization and limit pricing power, while delays in new product launches would postpone revenue contribution. Additional downside comes from potential tariff increases on imports from China or a ban on Chinese imports, which could compress gross margins and force more sourcing from Vietnam.

Ceribell Inc (CBLL) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ceribell Inc and is not a guaranteed prediction by Public.com or investment advice.

Ceribell Inc (CBLL) Analyst Forecast & Price Prediction

Get the latest Ceribell Inc (CBLL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Ceribell Inc (CBLL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ceribell Inc (CBLL) Forecast

Analysts have given Ceribell Inc (CBLL) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Ceribell Inc (CBLL) has a Strong Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ceribell Inc (CBLL)


Ceribell Inc (CBLL) Analyst Forecast & Price Prediction

Get the latest Ceribell Inc (CBLL) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Ceribell Inc (CBLL)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CBLL stock data and trends